M

MeiraGTx Holdings plc
D

MGTX

8.45000
USD
0.06
(0.66%)
مغلق
حجم التداول
7,630
الربح لكل سهم
-2
العائد الربحي
-
P/E
-4
حجم السوق
679,781,181
أصول ذات صلة الأخبار المقالات

العنوان: MeiraGTx Holdings plc

القطاع: Healthcare
الصناعة: Biotechnology
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.